*Program is based on a minimum of 25% of time allowed for questions and answers.
Introduction Segment |
|
8:00 – 8:30AM |
Welcome & Introductory Remarks Dr. Robert James Cusimano |
Basic Science Section |
|
8:30 – 9:15AM |
Angiosarcomas – a bench to bedside approach Dr Paul Huang – ICR, London |
9:15 – 10:00AM |
Intimal sarcomas – molecular landscape and profiling Dr Elizabeth Demicco – Mt Sinai Hospital, Toronto |
Q & A Session Dr Paul Huang – ICR, London & Dr Elizabeth Demicco – Mt Sinai Hospital, Toronto |
|
10:00 – 10:30AM | Break |
Clinical Session |
|
10:30 – 11:15AM |
Angiosarcoma of the heart – where do we stand clinically for systemic therapy? Dr Michael Wagner, Fred Hutch Cancer Centre, Seattle |
11:15AM – 12:00PM |
MDM2 and CDK4 aberrant tumours of the heart – where do we stand clinically? Dr Silvia Stacchiotti, Institut Tumori, Milan |
12:00 – 1:00PM | Lunch |
1:00 – 2:00PM |
Unaccredited Sessions on MDM2-P53 antagonists and checkpoint inhibitors |
2.00 – 2:45PM |
Session 1: Clinical Trials Moderator: Dr Robin Jones (Royal Marsden Hospital) , Dr Vinod Ravi (MD Anderson Cancer Centre) and Dr Albiruni Razak (Toronto Sarcoma Program) |
2.00 – 2:45PM |
Session 2: Patient Journey & Care: A Comparison Across Different Systems (USA, UK and Canada) Moderator: Dr Geoff Watson (Toronto Sarcoma Program), Dr Yolanda Augustin (Royal Marsden Hospital) and Ms Sudha Yalamanchili (MD Anderson Cancer Centre) |
2:45 – 3:00PM |
Closing Remarks & Introduction to the 9th Annual Toronto Cardiac Tumour Conference Dr. Robert James Cusimano |